The Senate health committee on Wednesday approved a bill that would exempt low-risk medical software and mobile apps from regulation by the Food and Drug Administration, so as not to stifle innovation by developers.

In a March 9 executive mark-up session, the committee passed by voice vote the bipartisan Medical Electronic Data Technology Enhancement for Consumers’ Health (MEDTECH) Act introduced by Sens. Michael Bennet (D-Colo.) and Orrin Hatch (R-Utah), designed to limit and clarify the FDA’s role regarding the regulation of administrative and financial software, wellness and lifestyle products, certain aspects of electronic health records, and clinical decision support software.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access